March 12, 2026
1 min read

Virta Health’s Nutrition Therapy Extends Survival by 34% in Stage IV Pancreatic Cancer Patients, New Clinical Trial Shows

DENVER, March 12, 2026–Virta Health, the leader in reversing metabolic disease, announced today results from a randomized, controlled Phase II clinical trial (RCT), offering an early signal that could reshape how advanced pancreatic cancer is treated. Conducted in partnership with USC Norris Comprehensive Cancer Center, Mayo Clinic, HonorHealth Research Institute, and others, the study was peer-reviewed and published in Cancer, revealing that Virta’s medically supervised, individualized nutriti

Leave a Reply

Your email address will not be published.

Previous Story

HEALTH FIRST: Dietitian shares tips to eat better this National Nutrition Month

Next Story

Commentary: National Nutrition Month provides opportunity to focus on how nutrition impacts performance, mission readiness

Previous Story

HEALTH FIRST: Dietitian shares tips to eat better this National Nutrition Month

Next Story

Commentary: National Nutrition Month provides opportunity to focus on how nutrition impacts performance, mission readiness

Latest from Blog

It’s Bean Time

The humble legume is the solution to America’s nutritional chaos. Post Views: 1
Go toTop